Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization: 75.75 M
The data is delayed by 15 minutes.
Description: Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States. The company?s principal products comprise Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. Its products also include Omeclamox-Pak, a triple therapy combination medication for the treatment of Helicobacter pylori infection and duodenal ulcer disease; and Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tenne
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||16.22 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-10.9%||Sales Growth - Q/Q||-6.88%||P/E|
|P/E To EPS Growth||P/S||2.02||P/BV||0.95||Price/Cash Per Share||1.43|
|Price/Free Cash Flow||11.6||ROA||2.37%||ROE||2.75%||ROI|
|Current Ratio||5.68||Quick Ratio||5.29||Long Term Debt/Equity||Debt Ratio||0.15|
|Gross Margin||86.23%||Operating Margin||8.41%||Net Profit Margin||5.82%||Dividend Payout Ratio|
|Cash From Financing Activities||-1.68 M||Cash From Investing Activities||-1.17 M||Cash From Operating Activities||2.03 M||Gross Profit||7.52 M|
|Net Profit||50 K||Operating Profit||Total Assets||92.19 M||Total Current Assets||67.55 M|
|Total Current Liabilities||11.89 M||Total Debt||Total Liabilities||12.82 M||Total Revenue||8.69 M|
|High 52 week||7||Low 52 week||4.73||Last close||5.53||Last change||-3.49%|
|RSI||53.94||Average true range||0.39||Beta||0.5||Volume||2.51 K|
|Simple moving average 20 days||-0.63%||Simple moving average 50 days||2.15%||Simple moving average 200 days||-4.66%|
|Performance Week||-4.49%||Performance Month||11.72%||Performance Quart||-1.78%||Performance Half||-8.6%|
|Performance Year||-0.9%||Performance Year-to-date||-8.29%||Volatility daily||3.24%||Volatility weekly||7.24%|
|Volatility monthly||14.85%||Volatility yearly||51.42%||Relative Volume||74.79%||Average Volume||33.67 K|
|New High||New Low|
2019-11-05 17:45:10 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know
2019-11-05 11:24:04 | What's in Store for Cumberland Pharma CPIX in Q3 Earnings?
2019-11-05 09:35:00 | Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results
2019-11-02 10:30:11 | Is Cumberland Pharmaceuticals NASDAQ:CPIX Using Too Much Debt?
2019-10-30 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know
2019-10-24 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know
2019-10-16 17:50:09 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know
2019-10-10 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know
2019-10-04 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know
2019-09-26 11:01:03 | New Strong Buy Stocks for September 26th
2019-09-25 12:25:50 | Does Cumberland Pharmaceuticals Inc.'s NASDAQ:CPIX CEO Pay Matter?
2019-09-19 08:01:12 | New Strong Buy Stocks for September 19th
2019-09-13 09:25:01 | Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
2019-09-12 10:26:02 | New Strong Buy Stocks for September 12th
2019-09-12 09:00:01 | Cumberland CPIX Upgraded to Strong Buy: What Does It Mean for the Stock?
2019-09-10 11:46:03 | Theravance Announces Positive Early Data on JAK Inhibitor
2019-09-09 09:50:01 | New Strong Buy Stocks for September 9th
2019-09-06 10:33:28 | Edited Transcript of CPIX earnings conference call or presentation 14-Aug-19 8:30pm GMT
2019-09-06 08:45:12 | Here is Why Growth Investors Should Buy Cumberland CPIX Now
2019-09-05 09:38:01 | New Strong Buy Stocks for September 5th
2019-08-21 08:45:12 | Here is Why Growth Investors Should Buy Cumberland CPIX Now
2019-08-14 17:25:09 | Cumberland Pharmaceuticals CPIX Q2 Earnings Beat Estimates
2019-08-14 16:05:00 | Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter
2019-08-14 07:24:43 | Q2 Earnings Preview For Cumberland
2019-08-07 13:45:00 | Cumberland Pharmaceuticals To Announce Second Quarter 2019 Financial Results
2019-07-18 14:33:10 | New antibiotics desperately needed for rising tide of drug-resistant ‘superbugs’
2019-07-12 14:30:01 | When Will Cumberland Pharmaceuticals Inc. NASDAQ:CPIX Turn A Profit?
2019-07-05 10:09:02 | Dova Pharmaceuticals DOVA in Focus: Stock Moves 9.1% Higher
2019-06-26 08:32:12 | Acer Shares Down on FDA's CRL for Genetic Disorder Treatment
2019-06-25 17:50:09 | Cumberland Pharmaceuticals CPIX Gains As Market Dips: What You Should Know
2019-06-25 09:28:01 | Why Taro Pharmaceutical TARO Could Be Positioned for a Slump
2019-06-19 17:50:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know
2019-06-19 08:25:21 | The city's newest public company wants to build a new industry in Nashville
2019-06-18 10:25:56 | Publicly traded San Diego firm moving HQ to Nashville
2019-06-04 09:30:01 | Has Cumberland Pharmaceuticals CPIX Outpaced Other Medical Stocks This Year?
2019-06-04 08:39:12 | Nektar NKTR in Focus: Stock Moves 8.8% Higher
2019-06-03 08:31:12 | 5 Stocks That Survived May's Market Mayhem
2019-05-23 09:11:01 | New Strong Buy Stocks for May 23rd
2019-05-23 09:00:01 | Cumberland CPIX Upgraded to Strong Buy: Here's What You Should Know
2019-05-17 08:45:12 | Is Cumberland CPIX a Solid Growth Stock? 3 Reasons to Think " Yes "
2019-05-15 09:35:00 | Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China
2019-05-14 21:04:40 | Edited Transcript of CPIX earnings conference call or presentation 14-May-19 8:30pm GMT
2019-05-14 17:45:09 | Cumberland Pharmaceuticals CPIX Q1 Earnings and Revenues Beat Estimates
2019-05-14 16:41:34 | Cumberland: 1Q Earnings Snapshot
2019-05-14 16:05:00 | Nashville health care company's strategic review leads it to China